Cargando…

Editorial: Minimally-invasive treatment for genitourinary cancers: what comes next?

Detalles Bibliográficos
Autores principales:	Chierigo, Francesco, Flammia, Rocco Simone, Mantica, Guglielmo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546408/ https://www.ncbi.nlm.nih.gov/pubmed/37795438 http://dx.doi.org/10.3389/fonc.2023.1285730

Ejemplares similares

Editorial: Penile cancer in genitourinary oncology
por: Buosi, Keini, et al.
Publicado: (2022)

Editorial: Reviews in genitourinary oncology
por: Arcangeli, Stefano, et al.
Publicado: (2023)

Editorial: Methods in genitourinary oncology
por: Jang, Albert, et al.
Publicado: (2023)

Editorial: Biomarkers in Genitourinary Cancers, Volume I
por: Videira, Paula Alexandra, et al.
Publicado: (2022)

Editorial: Biomarkers in genitourinary cancers: Volume II
por: Yuasa, Takeshi
Publicado: (2022)

Editorial: Emerging Biomarkers in Genitourinary Tumors
por: Montironi, Rodolfo, et al.
Publicado: (2019)

Editorial: Women in genitourinary oncology: 2021
por: Štifter, Sanja
Publicado: (2022)

Racial/ethnic disparities in the distribution and effect of type and number of high-risk criteria on mortality in prostate cancer patients treated with radiotherapy
por: Chierigo, Francesco, et al.
Publicado: (2022)

Editorial: The mechanism of tumor evolution and microenvironmental changes of genitourinary oncology in clinical diagnosis and treatment
por: Lu, Jiahe, et al.
Publicado: (2023)

What comes next?
por: Naeem, Shahid
Publicado: (2019)

Microbiome and Cancers, With Focus on Genitourinary Tumors
por: Cimadamore, Alessia, et al.
Publicado: (2019)

Mitochondrialand: What Will Come Next?
por: Pizzo, Paola, et al.
Publicado: (2021)

Editorial: Circulating molecular biomarkers: next-generation tools for monitoring minimal residual disease in cancer patients
por: Amoozgar, Zohreh, et al.
Publicado: (2023)

Editorial: Sexual selection and environmental change: what do we know and what comes next?
por: Pilakouta, Natalie, et al.
Publicado: (2021)

Exercise Endocrinology: “What Comes Next?”
por: Hackney, Anthony C., et al.
Publicado: (2021)

Emerging Molecular Technologies in Genitourinary Tumors
por: Giunchi, Francesca, et al.
Publicado: (2018)

Quinolones as a Potential Drug in Genitourinary Cancer Treatment—A Literature Review
por: Kloskowski, Tomasz, et al.
Publicado: (2022)

The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next?
por: Harris, Philip E., et al.
Publicado: (2022)

Genitourinary Oncology: Current Status and Future Challenges
por: Bukowski, Ronald M.
Publicado: (2011)

Immunotherapy Combined With Radiation Therapy for Genitourinary Malignancies
por: Ukleja, Jacob, et al.
Publicado: (2021)

Genetics of RA susceptibility, what comes next?
por: Ding, James, et al.
Publicado: (2015)

Tregs: Where We Are and What Comes Next?
por: Zhao, Hai, et al.
Publicado: (2017)

COVID-19: What Comes Next for IRs
por: Hausegger, Klaus A.
Publicado: (2020)

What comes next in the COVID-19 pandemic?
por: Fisher, Dale, et al.
Publicado: (2022)

Intravesical Therapy for Non-Muscle-Invasive Bladder Cancer: What Is the Real Impact of Squamous Cell Carcinoma Variant on Oncological Outcomes?
por: Mantica, Guglielmo, et al.
Publicado: (2022)

Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients
por: Hoeh, Benedikt, et al.
Publicado: (2021)

Impact of Circadian Rhythms on the Development and Clinical Management of Genitourinary Cancers
por: Kaur, Priya, et al.
Publicado: (2022)

Editorial: Genitourinary syndrome of menopause
por: Eleutério Junior, José, et al.
Publicado: (2022)

Minimally-invasive robotic pyeloplasty: the ‘window technique’
por: Gaboardi, Franco, et al.
Publicado: (2019)

The association of the type and number of D’Amico high-risk criteria with rates of pathologically non-organ-confined prostate cancer
por: Chierigo, Francesco, et al.
Publicado: (2023)

The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic
por: Izadmehr, Sudeh, et al.
Publicado: (2021)

Current State of Personalized Genitourinary Cancer Radiotherapy in the Era of Precision Medicine
por: Kamran, Sophia C., et al.
Publicado: (2021)

Geriatric assessment in the older adult with genitourinary cancer: A narrative review
por: Singhal, Surbhi, et al.
Publicado: (2023)

Drug therapy of overactive bladder - What is coming next?
por: Andersson, Karl-Erik
Publicado: (2015)

An Update on Patent Ductus Arteriosus and What is Coming Next
por: Erdeve, Ömer, et al.
Publicado: (2022)

From women to women—hematuria during therapy for metastatic breast cancer, what to suspect and when to be alarmed; Bladder metastasis from breast cancer—our experience and a systematic literature review
por: Malinaric, Rafaela, et al.
Publicado: (2022)

Atypical granular cell tumor of the urinary bladder: A case report and literature review
por: Tufano, Antonio, et al.
Publicado: (2021)

Editorial: Next generation staging in head and neck cancers
por: Iyer, N. Gopalakrishna, et al.
Publicado: (2022)

A Nomogram Model to Predict Prognosis of Patients With Genitourinary Sarcoma
por: Li, Linde, et al.
Publicado: (2021)

Editorial: Education in Genitourinary Surgery 2022
por: Siech, Carolin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0a1d6a2e0e22ff1v43l0thn2sk